GeneType
Bronwyn Christie is an accomplished finance professional with extensive experience in corporate governance and financial management. Serving as the CFO and Company Secretary at ImmunAid Limited since March 2014 and as Financial Controller and Company Secretary at Genetic Technologies Ltd since March 2008, Bronwyn has demonstrated expertise in strategic financial oversight. Prior experience includes a significant tenure at BASF from 1984 to January 2008, where Bronwyn held roles as Senior Financial Accountant, Company Secretary, and Public Officer. Educational qualifications include a Graduate Diploma in Corporate Governance from Company Secretaries Australia, CPA certification from the Society of Certified Practicing Accountants, and a Bachelor of Commerce in Accounting and Commercial Law from the University of Melbourne.
This person is not in any teams
GeneType
Genetype - Unlocking personalised preventative health Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology. Significant progress has been made in understanding the role of hereditary risk in chronic disease, however, many chronic conditions cannot be predicted by this risk alone. We’re transforming the conversation. Transitioning from a one-size-fits-all model to personalised, predictive health assessment – where each person has the information, they need to manage their health according to their own risk. Backed by over 20 years of experience, our doctors, scientist and technicians are translating genetic information into multi-tests that uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset. We’re empowering physicians to improve health outcomes for people around the world. Tracking disease to its source. Enabling a new era of personalised medicine.